Biopharmaceutical firm pays $7.5M to settle kickback claims

NEWARK, N.J. (AP) — Federal prosecutors say a biopharmaceutical firm will pay more than $7.5 million to resolve claims it paid kickbacks to doctors to persuade them to prescribe its fentanyl-based drug Abstral.